Amdocs Limited (DOX) - What Are Analysts Saying About This Stock?

Key Points

• Analyst consensus is “Hold”: Two analysts rate Amdocs a sell, two a hold and three a buy, with an average 12-month price target of $86.67.
• Amdocs reported quarterly EPS of $1.84, matching estimates, while revenue rose 2.7% year over year to $1.17 billion but fell slightly short of expectations.
• The company declared a quarterly dividend of $0.569 per share, equivalent to an annualized yield of about 3.8%; institutional investors and hedge funds own 92.02% of the stock.

Shares of Amdocs Limited (NASDAQ:DOX - Get Free Report) have been assigned an average rating of "Hold" from the seven research firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $86.67.

A number of analysts have recently weighed in on DOX shares. Weiss Ratings cut shares of Amdocs from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Thursday. KeyCorp started coverage on shares of Amdocs in a research note on Monday, June 29th. They issued a "sector weight" rating on the stock. Finally, Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, August 29th.

Amdocs Stock Performance

Shares of DOX stock traded up $0.76 during trading on Tuesday, reaching $59.51. The company had a trading volume of 17,013 shares, compared to its average volume of 1,238,509. The firm's 50 day simple moving average is $59.76 and its two-hundred day simple moving average is $59.39. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94. Amdocs has a one year low of $49.74 and a one year high of $85.63. The company has a market capitalization of $6.42 billion, a PE ratio of 14.17, a PEG ratio of 0.94 and a beta of 0.44.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Thursday, August 6th. The technology company reported $1.84 earnings per share for the quarter, hitting the consensus estimate of $1.84. Amdocs had a return on equity of 20.28% and a net margin of 9.75%. The firm had revenue of $1.17 billion during the quarter, compared to analyst estimates of $1.18 billion. During the same period in the previous year, the company earned $1.72 EPS. The company's revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts forecast that Amdocs will post 6.56 earnings per share for the current year.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.5690 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date is Wednesday, September 30th. Amdocs's dividend payout ratio is 54.05%.

Institutional Investors Weigh In On Amdocs

Several hedge funds and other institutional investors have recently made changes to their positions in DOX. GAMMA Investing LLC increased its stake in shares of Amdocs by 71.7% in the third quarter. GAMMA Investing LLC now owns 2,962 shares of the technology company's stock worth $169,000 after purchasing an additional 1,237 shares during the period. Farther Finance Advisors LLC boosted its stake in Amdocs by 16.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,292 shares of the technology company's stock valued at $74,000 after purchasing an additional 182 shares during the period. Steph & Co. grew its holdings in Amdocs by 251.7% in the 3rd quarter. Steph & Co. now owns 9,454 shares of the technology company's stock valued at $541,000 after buying an additional 6,766 shares during the last quarter. CX Institutional grew its holdings in Amdocs by 42.3% in the 3rd quarter. CX Institutional now owns 8,146 shares of the technology company's stock valued at $466,000 after buying an additional 2,421 shares during the last quarter. Finally, Versant Capital Management Inc grew its holdings in Amdocs by 3,340.6% in the 3rd quarter. Versant Capital Management Inc now owns 1,101 shares of the technology company's stock valued at $63,000 after buying an additional 1,069 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.

About Amdocs

Amdocs Limited NASDAQ: DOX is a global provider of software and services for communications, media and entertainment companies. Its offerings help service providers manage customer relationships, billing, product catalogs, ordering, network operations and digital experiences across consumer and enterprise markets.

The company provides business support systems and operational support systems, along with cloud-based platforms, artificial intelligence and data solutions, cybersecurity, network services and managed services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.